For Newsom, 2026 Invites Closer Scrutiny of His Many Promises

California Gov. Gavin Newsom is poised in a few days to finally deliver on one of his signature health care policies: a state-run program to provide low-cost insulin.

But a close look shows the results aren’t quite what the governor promised.

The project blew past Newsom’s self-imposed 2024 deadline and the drug won’t be manufactured in California, as he once pledged.

Instead, his administration used most of the $50 million it set aside for that pharma plant to plug a state budget hole, then arranged to ship in insulin from Malaysia. Meanwhile, state officials won’t say when California’s 3 million ...